Brief: Sanofi Q2 Business EPS At €2.09 Beats Consensus
30/07/2026 06:30
BRIEF-Sanofi Q2 Business EPS At €2.09 Beats Consensus July 30 (Reuters) - Sanofi SA SASY.PA:
Q2 BUSINESS EPS €2.09 (CONSENSUS: €1.90)
Q2 BUSINESS OPERATING INCOME €3.29 BILLION (CONSENSUS: €2.97 BILLION)
Q2 FREE CASH FLOW €2.67 BILLION
GUIDANCE 2026 UPGRADED: SALES NOW EXPECTED TO GROW BY AROUND 10% AT CER; BUSINESS EPS AT CER EXPECTED TO GROW SLIGHTLY FASTER THAN SALES
Q2 NET SALES €11.60 BILLION (VARA CONSENSUS: €10.85 BILLION)
Source text: ID:nGNX7DlpxQ
Further company coverage: SASY.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle